Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
microbiome
3
×
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
amgen
astrazeneca
bristol-myers squibb
clinical trials
deals
diagnostics
eli lilly
hepatitis b
What
bio
drug
roundup
acquisitions
advantages
approved
bar
biggest
brings
build
buy
ceo
companies
company’s
daniel
debut
digital
disease
dyne’s
epidemic
expect
fatty
fda
frenzied
gamble
gilead
growing
known
led
liver
market
medco’s
merck
microbiome
mover
moves
nash
new
news
openly
Language
unset
Current search:
microbiome
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
